HDAC9 and acute lymphoblastic leukemia: MOLT-4, an acute lymphoblastic leukemia cell line, possess a cis combination of the L1601PΔP heterodimerization mutation and PEST domain deletion and are highly sensitive to Notch and pan-HDAC inhibitors (103, 104).